1 |
Jung KM, Piomelli D. Cannabinoids and endocannabinoids. In: Pfaff DW, Volkow ND, editors. Neuroscience in the 21st century: from basic to clinical. New York (NY): Springer New York; 2016. p.1811-41.
|
2 |
Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 2020;16:9-29.
DOI
|
3 |
Shariff JA, Ahluwalia KP, Papapanou PN. Relationship between frequent recreational cannabis (marijuana and hashish) use and periodontitis in adults in the United States: National Health and Nutrition Examination Survey 2011 to 2012. J Periodontol 2017;88:273-80.
DOI
|
4 |
Rawal SY, Tatakis DN, Tipton DA. Periodontal and oral manifestations of marijuana use. J Tenn Dent Assoc 2012;92:26-31.
|
5 |
Cuba LF, Salum FG, Guimaraes FS, Cherubini K, Borghetti RL, de Figueiredo MA. Cannabidiol on 5-FUinduced oral mucositis in mice. Oral Dis 2020;26:1483-93.
DOI
|
6 |
Zhang F, Ozdemir B, Nguyen PQ, Andrukhov O, Rausch-Fan X. Methanandamide diminish the Porphyromonas gingivalis lipopolysaccharide induced response in human periodontal ligament cells. BMC Oral Health 2020;20:107.
DOI
|
7 |
Jager A, Setiawan M, Beins E, Schmidt-Wolf I, Konermann A. Analogous modulation of inflammatory responses by the endocannabinoid system in periodontal ligament cells and microglia. Head Face Med 2020;16:26.
DOI
|
8 |
Abidi AH, Alghamdi SS, Dabbous MK, Tipton DA, Mustafa SM, Moore BM. Cannabinoid type-2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL-1β stimulated primary human periodontal ligament fibroblasts. J Periodontal Res 2020;55:762-83.
DOI
|
9 |
Bartel SJ, Sherry SB, Stewart SH. Self-isolation: a significant contributor to cannabis use during the COVID-19 pandemic. Subst Abus. Forthcoming 2020.
|
10 |
Vidot DC, Islam JY, Marlene Camacho-Rivera , Harrell MB, Rao DR, Chavez JV, et al. The COVID-19 cannabis health study: results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States. J Addict Dis. Forthcoming 2020.
|
11 |
Xiong W, Cui T, Cheng K, Yang F, Chen SR, Willenbring D, et al. Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. J Exp Med 2012;209:1121-34.
DOI
|
12 |
Chisini LA, Cademartori MG, Francia A, Mederos M, Grazioli G, Conde MC, et al. Is the use of Cannabis associated with periodontitis? A systematic review and meta-analysis. J Periodontal Res 2019;54:311-7.
DOI
|
13 |
Abidi AH, Presley CS, Dabbous M, Tipton DA, Mustafa SM, Moore BM 2nd. Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts. Arch Oral Biol 2018;87:79-85.
DOI
|